GPR43 (free fatty acid receptor 2) is known to regulate energy balance in the host through the gastrointestinal and adipose tissues, and is being explored as a potential therapeutic alternative for metabolic diseases [115,116]. This evidence concerns the gene FFAR2 and metabolic disease.